The Food and Drug Administration has launched a safety review of mifepristone, the drug used for medicated abortions, according to the Wall Street Journal.

The review comes as some anti-abortion advocates have grown increasingly frustrated with the Trump administration, arguing it has moved too slowly on promises to revisit federal abortion pill regulations ahead of the midterm elections.